En Es
Categories

Novacyt Group

The Novacyt Group is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialization, contract design and manufacturing. The company's lead business units comprise of Primerdesign and Lab2 ...
Products Covid-19Summary
Close

Covid-19 Novacyt Group

Clinical Laboratory

SARS-CoV-2 IgG EIA ELISA Test
Microgen Bioproducts SARS-CoV-2 IgG EIA

The Microgen Bioproducts SARS-CoV-2 IgG EIA is a high-performance ELISA test for the qualitative detection of IgG antibodies. The test is intended for screening patients suspected of being infected with the SARS-CoV-2 virus. Provided in a convenient 480 reaction format (5×96 well plates) including all additional reagents to perform the assay. This test is functional with human serum and plasma samples.
More details

SARS-CoV-2 IgG Lateral Flow Test
PathFlow SARS-CoV-2 IgG

The PathFlow SARS-CoV-2 IgG is an easy-to-use, rapid, lateral flow test, for the detection of antibodies in human whole blood, serum, or plasma specimen(s). The assay provides detection of IgG antibodies to SARS-CoV-2 spike (S) protein, receptor binding domain (RBD) and nucleocapsid (N) protein. The test is to aid in the identification of individuals with an adaptive immune response to SARSCoV-2; derived from wild type infection or as a response to vaccination.
More details

Direct-To-PCR SARS-CoV-2 Test
COVID-HT Direct

COVID-HT Direct is a next generation high-throughput direct-to-PCR SARS-CoV-2 test for high-throughput laboratories that has been CE Mark approved. The test eliminates the need for automated extraction systems in a high-volume PCR laboratory, reducing processing time, cost and labor of testing by up to 30%.
More details

SARS-CoV-2 Rapid Antigen Test
PathFlow COVID-19 Rapid Antigen Pro

PathFlow COVID-19 Rapid Antigen Pro is a CE Marked LFT for professional use detecting SARS-CoV-2 antigens using either anterior nasal samples or nasopharyngeal samples to provide results in approximately 15 minutes. When using nasal swab specimens, the test demonstrated a sensitivity of 93.5% and specificity of 99.3% and when using nasopharyngeal swab specimens, it demonstrated sensitivity of 93.4% and specificity of 99.4%.
More details

COVID-19 Three-Gene Assay
genesig COVID-19 3G

genesig COVID-19 3G is a CE-Marked three-gene assay to detect the ORF1ab, M gene, and S gene targets of SARS-CoV-2, enabling fulfillment of certain international testing requirements, including Fit to Fly Certificate, Test to Release and US Food and Drug Administration regulations. The genesig COVID-19 3G is CE-IVD marked and intended for in vitro diagnostic use in Europe.
More details

SARS-CoV-2 Mutations Assay
SNPsig EscapePLEX SARS-CoV-2

SNPsig EscapePLEX SARS-CoV-2 is a first-to-market assay panel in a single kit able to detect the four most critical SARS-CoV-2 mutations currently recognized, combined with a confirmatory two-gene assay for COVID-19. The research-use-only kit detects the biologically significant ‘escape’ mutations E484K, K417N, K417T and P681R, present in the Alpha, Beta, Gamma and Delta Variants of Concern (VoC), and also incorporates the two gene (ORF1ab and M) assay to provide a confirmatory detection of SARS-CoV-2.
More details

COVID-19 Portable Test Kit
VersaLab Portable

The VersaLab Portable is a rapid, lightweight COVID-19 test kit designed to provide rapid turnaround polymerase chain reaction (PCR) testing on-site. VersaLab Portable aims to broaden access to affordable testing in areas that lack the infrastructure for laboratory-based testing with gold standard PCR results from optimized reagents.
More details
Close

About Novacyt Group

The Novacyt Group is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialization, contract design and manufacturing. The company's lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high-quality assays and reagents worldwide. The Group directly serves microbiology, hematology and serology markets as do its global partners, which include major corporates.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 Mutations Assay

SARS-CoV-2 Mutations Assay

Model: SNPsig EscapePLEX SARS-CoV-2
Request Information

Description:

SNPsig EscapePLEX SARS-CoV-2 is a first-to-market assay panel in a single kit able to detect the four most critical SARS-CoV-2 mutations currently recognized, combined with a confirmatory two-gene assay for COVID-19. The research-use-only kit detects the biologically significant ‘escape’ mutations E484K, K417N, K417T and P681R, present in the Alpha, Beta, Gamma and Delta Variants of Concern (VoC), and also incorporates the two gene (ORF1ab and M) assay to provide a confirmatory detection of SARS-CoV-2.

Features

Features

• The ability to detect SARS-CoV-2 and its important Variants of Concern in just one kit
• Intended for use as a reflex test for positive samples; a more time and cost-efficient alternative to next generation sequencing (NGS) and more informative than S gene target failure (SGTF)
• Streamlined workflow for easy use with readily prepared Master Mix
• Multi-platform capability
• No cold chain shipping
• Results in under two hours Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Novacyt Group (SARS-CoV-2 Mutations Assay)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions